Young Cha
McLean Hospital(US)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Biomedical Ethics and Regulation, Nuclear Receptors and Signaling, MicroRNA in disease regulation
Most-Cited Works
- → Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease(2020)501 cited
- → Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis(2017)180 cited
- → Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models(2019)179 cited
- → Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects(2018)135 cited
- → Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease(2023)111 cited
- → PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line(2013)90 cited
- → SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes(2021)62 cited
- → Lefty1 and Lefty2 Control the Balance Between Self-Renewal and Pluripotent Differentiation of Mouse Embryonic Stem Cells(2013)53 cited
- → An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models(2023)43 cited
- Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells.(2008)